Mediar bags $105 mn from big pharmas to pursue fibrosis treatments
Mediar Therapeutics gets $105 million financing from Novartis, Pfizer, Eli Lilly and Bristol Myers to advance portfolio of first-in-class fibrosis therapies.
Medical
Pharma
Health
Medical
Pharma
Fifty-five nations facing a shortage of health workers: WHO
he WHO has identified 55 nations vulnerable to a shortfall in health workers needed to fulfil the UN’s charter for universal health coverage.
Drugs
Medical
Pharma
FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Drugs
Medical
Pharma
Sanofi acquires Provention Bio for $2.9 billion to boost its diabetes portfolio
Sanofi acquires Provention Bio, and its TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).
Drugs
Health
Medical
Leukaemia drug effective in treating breast cancer metastatic relapse
A mice study showed promising results in treating secondary recurrence of breast cancer in lungs
Drugs
Medical
Pharma
Pfizer to buy Seagen for $43 billion to fortify cancer portfolio
Pfizer will acquire Seagen for $43 billion to beef up its cancer portfolio, with COVID-19 vaccine sales forecast to plummet.
Health
Medical
Dim lights hours before sleep to avoid gestational diabetes mellitus
Exposure to bright lights before sleep can induce gestational diabetes mellitus in pregnant women, a study by Northwestern Medicine, an affiliate of Northwestern.
Health
Medical
WHO advocates ‘social math’ to highlight global road safety
The WHO has advocated a ‘social math’ technique to magnify the issue of road safety globally for non-governmental organisations.
Drugs
Medical
Pharma
Merck says trial hypertension drug enhances patients’ walk time
Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.
Drugs
Medical
Alembic Pharma gets USFDA approval for cancer treatment drug
Alembic Pharmaceuticals got the USFDA note for a generic cancer treatment drug